The Iranian Consensus on Self-Monitoring of Blood Glucose: An Expert Consensus.

BACKGROUND

Self-monitoring of blood glucose (SMBG) has long been a key aspect of diabetes management. However, with recent advancements in continuous glucose monitoring (CGM), high-income countries have increasingly shifted toward CGM use. In contrast, due to challenges in CGM accessibility and affordability in resource-limited settings, SMBG remains the most widely used method. The low uptake of SMBG in such contexts, despite its importance in diabetes self-management, highlights the urgent need for a national consensus in Iran.

METHODS

A multidisciplinary team of Iranian experts in endocrinology and diabetes care, comprising members of the Gabric Diabetes Association, the Iranian Diabetes Society, and faculty from leading medical universities, developed the first Iranian expert consensus on SMBG. To facilitate implementation in clinical practice, the consensus was officially endorsed by the Ministry of Health and Medical Education of Iran.

RESULTS

Given the affordability challenges in Iran, this consensus offers recommendations for both Standard and Limited Care settings to promote a more structured and effective approach to SMBG for healthcare providers and people living with diabetes.

CONCLUSION

A nationally developed SMBG guideline has been developed in Iran, offering frequency and timing recommendations based on diabetes type, treatment regimen, and level of glycemic control, aligned with international guidelines. Given the crucial role of SMBG in diabetes care, this national consensus aims to be implemented in clinical practice and policy-making.